Under copyright Constraint(s) on Use: This work is protected by the U.S. Copyright Law (Title 17, U.S.C.). Use of this work beyond that allowed by "fair use" requires written permission of the UC Regents. Responsibility for obtaining permissions and any use and distribution of this work rests exclusively with the user and not the UC San Diego Library. Inquiries can be made to the UC San Diego Library program having custody of the work. Use: This work is available from the UC San Diego Library. This digital copy of the work is intended to support research, teaching, and private study.
Rights Holder and Contact
UC Regents
Description
Mr. Lawrence A. Bock is a Special Limited Partner at Lux Capital Management. Mr. Bock also founded the firm. He is a Co-Founder of Nanosys Inc. Previously, he was a Managing General Partner at CW Group, Inc. since June 1998. At CW Group, he managed the firm's West Coast office focusing on technology based start-ups and is based at the firm’s San Diego office. Mr. Bock has more than 20 years of leadership in the life sciences and nanotechnology industries and has been a Co-Founder of over a dozen companies and has served as the Chief Executive Officer of six. He served as a Managing General Partner at CW Group from June 1998 to April 2004. From 1988 to June 1998, prior to joining CW Group, Mr. Bock was with Avalon Ventures as a General Partner. He was with the firm for nine years and was involved in the early stage financing of 15 highly successful biotechnology companies, including Vertex Pharmaceuticals, Pharmacopeia, Inc., Neurocrine Biosciences Inc., ARIAD Pharmaceuticals, Metra Biosystems and a recent example, Caliper Technologies Corp. Mr. Bock has been the Founder and initial Chief Executive Officer at Metra Biosystems, Inc., Neurocrine Biosciences, Inc., Pharmacopeia, Inc., Argonaut Technologies, Inc., and Caliper Technologies Corp. He was a Co-Founder of ARIAD Pharmaceuticals, Inc., Athena Neurosciences Inc., GenPharm International, Vertex Pharmaceuticals Inc., Onyx Pharmaceuticals Inc., and Illumina Inc. Mr. Bock began his career in infectious disease research at Genetic and later joined Fairfield Venture Partners where he participated in financing a dozen biotechnology companies. He has been a Director of Nanosys Inc. since 2001 and is the Executive Chairman of Nanosys Inc. Mr. Bock serves as a Member of the Advisory Board and the Technology Advisory Board of the Nan Business Alliance. He served as a Director of FEI Co. since December 16, 2004 until August 6, 2012. Mr. Bock also currently serves as the Chairman of Lux Ventures’ Advisory Board of industry experts advising the investment team. He is also the Founder and Executive Director of the USA Science and Engineering Festival. He holds an M.B.A. from the Anderson School at the University of California, Los Angeles and a B.A. in Liberal Arts from Bowdoin College, both with highest honors. Mr. Bock also graduated with a Biochemistry degree from Bowdoin College. [Source: Bloomberg Businessweek] Born digital Special Collections & Archives, UC San Diego, La Jolla, 92093-0175 (https://lib.ucsd.edu/sca) Bock, Larry. Interview conducted by Mark Jones, June 10, 2014. The San Diego Technology Archive (SDTA), UC San Diego Library, La Jolla, CA.
Type
text
Identifier
ark:/20775/bb34840569
Subject
Life sciences Biotechnology Nanotechnology Lux Capital (Firm) Nanosys Metra Biosystems Inc CW Group Avalon Ventures San Diego (Calif.)
If you're wondering about permissions and what you can do with this item, a good starting point is the "rights information" on this page. See our terms of use for more tips.
Share your story
Has Calisphere helped you advance your research, complete a project, or find something meaningful? We'd love to hear about it; please send us a message.
